These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1690486)

  • 1. [Conservative, non-hormonal treatment of benign prostatic hyperplasia].
    Dreikorn K; Richter R; Schönhöfer PS
    Urologe A; 1990 Jan; 29(1):8-16; discussion 17-8. PubMed ID: 1690486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective study of the treatment of 329 patients with prostatism syndrome and review of the literature].
    Fernández Gómez JM; San Martín Blanco A; Sahagún Argüello JL; Rábade Rey CJ; Pérez García FJ; Alonso Sainz F
    Arch Esp Urol; 1996 Nov; 49(9):929-43. PubMed ID: 9133293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of benign prostatic hyperplasia other than with hormones or alpha blockers.
    Fitzpatrick JM; Dreikorn K; Habib F; Mebust WK; Perrin P; Schulze HK
    Prog Clin Biol Res; 1994; 386():303-9. PubMed ID: 7528399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of alpha blockers in the treatment of BPH: a critical review of clinical results.
    Von Heland M; Casale P
    Arch Esp Urol; 1994 Nov; 47(9):873-81; discussion 881-2. PubMed ID: 7530943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha blockade for the treatment of benign prostatic hyperplasia.
    Lepor H
    Urol Clin North Am; 1995 May; 22(2):375-86. PubMed ID: 7539182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of BPH.
    Roylance P; Gibelin B; Espié J
    Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha adrenergic antagonists for the treatment of symptomatic BPH.
    Lepor H
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):151-5. PubMed ID: 2469658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia.
    Lepor H
    Urol Clin North Am; 1990 Aug; 17(3):651-9. PubMed ID: 1695785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of benign prostatic hyperplasia with alpha receptor blockers].
    Stockamp K
    Urologe A; 1995 Jan; 34(1):3-8. PubMed ID: 7533449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
    Martorana G; Giberti C; Di Silverio F; von Heland M; Rigatti P; Colombo R; Casadei G; Pacifico P
    Eur Urol; 1997; 32(1):47-53. PubMed ID: 9266231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic stents for benign prostatic hyperplasia.
    Klein LT; Kaplan SA
    J Long Term Eff Med Implants; 1997; 7(1):101-14. PubMed ID: 10168540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin-alpha-1-adrenergic antagonists drug in the long-term (3 years). Management of benign prostatic hyperplasia.
    Dutkiewicz S
    Mater Med Pol; 1996; 28(3):93-102. PubMed ID: 9167419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive treatment of benign prostatic hyperplasia. Where do we stand in 2005.
    Al-Ansari AA; Shokeir AA
    Saudi Med J; 2006 Mar; 27(3):299-304. PubMed ID: 16532087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.